bisacodyl has been researched along with Bladder Cancer in 1 studies
Bisacodyl: A diphenylmethane stimulant laxative used for the treatment of CONSTIPATION and for bowel evacuation. (From Martindale, The Extra Pharmacopoeia, 30th ed, p871)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Toyoda, K | 1 |
| Imaida, K | 1 |
| Shirai, T | 1 |
| Imazawa, T | 1 |
| Takahashi, M | 1 |
1 other study available for bisacodyl and Bladder Cancer
| Article | Year |
|---|---|
Relationship between bisacodyl-induced urolithiasis and rat urinary bladder tumorigenesis.
Topics: Administration, Oral; Animals; Bisacodyl; Body Weight; Dose-Response Relationship, Drug; Female; Mal | 1993 |